Citizens Financial Group Inc. RI Buys Shares of 5,423 The Clorox Company $CLX

Citizens Financial Group Inc. RI bought a new position in shares of The Clorox Company (NYSE:CLXFree Report) in the 2nd quarter, HoldingsChannel.com reports. The fund bought 5,423 shares of the company’s stock, valued at approximately $518,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CLX. BlackRock Inc. acquired a new stake in shares of Clorox in the 2nd quarter valued at approximately $958,640,000. Norges Bank acquired a new position in Clorox during the 4th quarter worth approximately $135,735,000. Bank of New York Mellon Corp bought a new position in Clorox in the 2nd quarter valued at approximately $123,154,000. Invesco Ltd. lifted its stake in Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after purchasing an additional 884,751 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its position in Clorox by 6,907.9% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after buying an additional 739,005 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

CLX stock opened at $108.12 on Thursday. The company has a market capitalization of $13.07 billion, a P/E ratio of 22.43, a PEG ratio of 3.16 and a beta of 0.54. The company has a fifty day moving average price of $98.62 and a 200-day moving average price of $103.16. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $128.90.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.91 billion. During the same period last year, the company earned $2.87 EPS. Clorox’s revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities analysts expect that The Clorox Company will post 5.8 EPS for the current year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $5.00 dividend on an annualized basis and a yield of 4.6%. This is a boost from Clorox’s previous quarterly dividend of $1.24. Clorox’s payout ratio is currently 103.73%.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Clorox’s dividend remains attractive relative to Church & Dwight’s, offering substantially more current income. However, the company has increased its dividend more cautiously, making the stock more appealing to income-focused investors than to growth-oriented investors. Two Consumer Staples, Two Dividend Strategies
  • Neutral Sentiment: Chief Executive Officer Linda Rendle and CFO Luc Bellet will participate in a fireside chat at the Barclays Global Consumer Staples Conference on September 9. The event could provide updates on demand, margins and the company’s outlook, but no new financial guidance was announced. Clorox to Present at Barclays Global Consumer Staples Conference
  • Negative Sentiment: Zacks Research lowered its Q1 2027 EPS forecast to $1.02 from $1.28 and cut its FY2027 estimate to $5.82 from $6.00. It also reduced estimates for Q1 and Q2 2028 and FY2028, while maintaining a “Strong Sell” rating. These revisions signal concern about near-term earnings momentum and are the clearest fundamental pressure on CLX. Zacks Research Estimate Changes
  • Negative Sentiment: An analyst cited weaker Hidden Valley Ranch dressing sales as consumers become more cautious about buying salad products amid a cyclospora outbreak. Any sustained decline in the brand could weigh on Clorox’s food business and quarterly revenue. Hidden Valley Ranch dressing may be a victim of this summer’s salad scare

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on CLX shares. Wells Fargo & Company boosted their target price on shares of Clorox from $95.00 to $102.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 4th. BNP Paribas Exane cut their price objective on Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a report on Monday, July 20th. The Goldman Sachs Group restated a “sell” rating and set a $83.00 price objective on shares of Clorox in a research report on Friday, May 1st. Barclays reaffirmed an “underweight” rating and issued a $84.00 target price on shares of Clorox in a report on Tuesday, August 4th. Finally, Morgan Stanley cut their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Twelve analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average price target of $102.40.

Check Out Our Latest Analysis on CLX

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.